XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Operating expenses:        
Research and development $ 856,478 $ 6,040 $ 922,924 $ 12,061
General and administrative 1,687,151 300,036 2,203,867 480,805
Total operating expenses 2,543,629 306,076 3,126,791 492,866
Operating loss (2,543,629) (306,076) (3,126,791) (492,866)
Other income (expense):        
Change in fair value of derivative liability   (26,500) (26,500) (26,500)
Interest income (expense), net 25,878 (12,124) 36,512 (16,237)
Grant income 208,261   365,699  
Total other income (expense) 234,139 (38,624) 375,711 (42,737)
Loss before income taxes (2,309,490) (344,700) (2,751,080) (535,603)
Income tax expense (benefit) 0 0 0 0
Net loss $ (2,309,490) $ (344,700) $ (2,751,080) $ (535,603)
Basic and Diluted loss per common share $ (0.34) $ (1.22) $ (0.48) $ (1.90)
Weighted average number of common shares outstanding, basic and diluted 6,860,847 282,614 5,730,158 282,614